Sofpromed Investigacion Clinica
Sofpromed Investigacion Clinica is recorded as a service provider in 13 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 13 of 13 trials · Latest update first
Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients
Sponsor Asoc Grupo Espanol De Investigacion En Sarcomas
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2 Evaluation of the Safety and Efficacy of Veonetinib (AL8326) in ≥2nd Line Small Cell Lung Cancer (SCLC), Non Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC) Treatment
Sponsor Advenchen Pharmaceuticals LLC
- Start (EU)
- Latest update
- Estimated end
Phase Ib/II multicohort trial of different schemes of PM14 in monotherapy and in combination with radiotherapy in soft tissue sarcomas and other solid tumors
Sponsor Asoc Grupo Espanol De Investigacion En Sarcomas
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized study to investigate the efficacy and safety of the tumor-targeting human antibody-cytokine fusion protein L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcoma
Sponsor Philogen S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase Ib/II multicohort trial of trabectedin, irinotecan, and low-dose radiation therapy in advanced/metastatic sarcomas.
Sponsor Asoc Grupo Espanol De Investigacion En Sarcomas
- Start (EU)
- Latest update
- Estimated end
Phase I/II randomized trial of LB-100 plus doxorubicin vs. doxorubicin alone in first line of advanced soft tissue sarcomas
Sponsor Asoc Grupo Espanol De Investigacion En Sarcomas
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
Sponsor Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase III study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line therapy in patients with advanced or metastatic soft tissue sarcoma
Sponsor Philogen S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas
Sponsor Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects with Recurrent or Metastatic Endometrial,Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma.
Sponsor Advenchen Laboratories LLC
- Start (EU)
- Latest update
- Estimated end
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met Exon14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Sponsor Apollomics Inc.
- Start (EU)
- Latest update
- Estimated end
Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
Sponsor Asociacion Europea Y Latinoamericana SELNET Para La Investigacion En Sarcomas
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A Phase 2 Evaluation of the Safety and Efficacy of AL8326 in ≥2nd Line Small Cell Lung Cancer (SCLC) Treatment
Sponsor Advenchen Pharmaceuticals LLC
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Sofpromed Investigacion Clinica?
The 2026-10-09 snapshot links Sofpromed Investigacion Clinica to 13 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Data management, Electronic data capture, among 8 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Sofpromed Investigacion Clinica?
The most frequently recorded therapeutic areas are Solid Tumor Oncology, Urology. Recorded phases include Phase 2, Phase 1. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Sofpromed Investigacion Clinica conducted?
The linked trials record locations in 6 countries, including Spain, Italy, France, Germany, Poland. These are trial locations, not confirmed office locations or countries where Sofpromed Investigacion Clinica delivered services.
What can this page tell me about Sofpromed Investigacion Clinica's trial experience?
Browse 13 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sofpromed Investigacion Clinica. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Sofpromed Investigacion Clinica S.L.